147806-85-7

Upstream product

• 147806-46-0 (E)-4-[(2R,3S,4S,6S)-4-Benzyloxy-6-benzyloxymethyl-3-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-pyran-2-yl]-2-methyl-but-2-en-1-ol 
• 100-39-0 benzyl bromide 
• 147806-45-9 (E)-4-[(2R,3S,4S,6S)-4-Benzyloxy-6-benzyloxymethyl-3-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-pyran-2-yl]-2-methyl-but-2-enoic acid ethyl ester 
• 143293-30-5 3,4:6,10-dianhydro-8,11-O-dibenzyl-3-C-methyl-7-O-(tert-butyldimethylsilyl)-1,2,5,9-tetradeoxy-D-threo-L-altro-undec-1-enitol 
• 147806-47-1 {(2S,3S)-3-[(2R,3S,4S,6S)-4-Benzyloxy-6-benzyloxymethyl-3-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-pyran-2-ylmethyl]-2-methyl-oxiranyl}-methanol 
• 143293-29-2 ((2R,3S,4S,6S)-2-Allyl-4-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-3-yloxy)-tert-butyl-dimethyl-silane 
• 143293-31-6 3,7:6,10-dianhydro-8,11-O-dibenzyl-3-C-methyl-1,2,5,9-tetradeoxy-D-threo-L-allo-undec-1-enitol 
• 147806-83-5 3,4:6,10-dianhydro-8,11-O-dibenzyl-3-C-methyl-1,2,5,9-tetradeoxy-D-threo-L-altro-undec-1-enitol 
• 147806-44-8 (2R,3S,4S,6S)-2-allyl-4-benzyloxy-6-benzyloxymethyl-tetrahydropyran-3-ol 
• 147806-42-6 (3aR,4R,6S,7aS)-4-Allyl-6-benzyloxymethyl-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran 
• 147806-43-7 (2R,3S,4S,6S)-2-Allyl-6-benzyloxymethyl-tetrahydro-pyran-3,4-diol 
• 122821-81-2 2,6-Anhydro-1-O-(tert-butyldiphenylsilyl)-3,7,8,9-tetradeoxy-4,5-O-isopropylidene-D-altro-non-8-enitol 
• 132375-56-5 ((3aR,4R,6S,7aS)-4-Allyl-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran-6-yl)-methanol 
• 147806-84-6 3,7:6,10-dianhydro-8,11-O-dibenzyl-3-C-methyl-4-O-(tert-butyldimethylsilyl)-1,2,5,9-tetradeoxy-D-threo-L-allo-undec-1-enitol 

Downstream Products

• 122271-91-4 Hemibrevetoxin-B 
• 143293-33-8 (2S,4S,4aS,5aR,10aS,11aR)-4-Benzyloxy-2-benzyloxymethyl-5a-methyl-decahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-9-one 
• 147806-90-4 (2S,4S,4aS,5aR,10aS,11aR)-4-Benzyloxy-2-benzyloxymethyl-5a-methyl-decahydro-1,5,10-trioxa-cyclohepta[b]naphthalene-9-thione 
• 147806-89-1 5,9:8,12-dianhydro-10,13-O-dibenzyl-5-C-methyl-2,3,4,7,11-pentadeoxy-D-threo-L-allo-trideconic acid 
• 147806-95-9 C₃₂H₄₀O₆S 
• 143293-36-1 C₃₂H₄₀O₇ 
• 147806-94-8 4-((2S,4S,4aS,5aR,8S,9R,10aS,11aR)-4-Benzyloxy-2-benzyloxymethyl-8-hydroxy-5a-methyl-dodecahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-9-yl)-butyric acid 
• 147806-92-6 Acetic acid (2S,4S,4aS,5aR,8S,9R,10aS,11aR)-4-benzyloxy-2-benzyloxymethyl-9-(4-hydroxy-butyl)-5a-methyl-dodecahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-8-yl ester 
• 147806-88-0 5,9:8,12-dianhydro-10,13-O-dibenzyl-5-C-methyl-6-O-(tert-butyldimethylsilyl)-2,3,4,7,11-pentadeoxy-D-threo-L-allo-trideconic acid 
• 143293-32-7 methyl 5,9:8,12-dianhydro-10,13-O-dibenzyl-5-C-methyl-6-O-(tert-butyldimethylsilyl)-2,3,4,7,11-pentadeoxy-D-threo-L-allo-trideconate 
• 147806-93-7 4-((2S,4S,4aS,5aR,8S,9R,10aS,11aR)-8-Acetoxy-4-benzyloxy-2-benzyloxymethyl-5a-methyl-dodecahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-9-yl)-butyric acid 
• 143293-35-0 (2S,4S,4aS,5aR,8S,9R,10aS,11aR)-4-Benzyloxy-2-benzyloxymethyl-9-[4-(tert-butyl-dimethyl-silanyloxy)-butyl]-5a-methyl-dodecahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-8-ol 
• 143293-34-9 [4-((2S,4S,4aS,5aR,10aS,11aR)-4-Benzyloxy-2-benzyloxymethyl-5a-methyl-2,3,4,4a,5a,6,7,10a,11,11a-decahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-9-yl)-butoxy]-tert-butyl-dimethyl-silane 
• 147806-91-5 Acetic acid (2S,4S,4aS,5aR,8S,9R,10aS,11aR)-4-benzyloxy-2-benzyloxymethyl-9-[4-(tert-butyl-dimethyl-silanyloxy)-butyl]-5a-methyl-dodecahydro-1,5,10-trioxa-cyclohepta[b]naphthalen-8-yl ester 

Relevant academic research and scientific papers

Total synthesis of hemibrevetoxin B and (7aα)-epi-hemibrevetoxin B

The total synthesis of hemibrevetoxin B(1) and (7aα)-epi-hemibrevetoxin B (2) is described. The synthesis of the epimer (2) was achieved through a convergent approach involving coupling of the carboxylic acid 17 carrying the bicyclic pyran system with the hydroxy compound 31 containing the monocyclic pyran system, thionation of the resulting diester 32 to the dithionoester 33, photolytic closure to the oxepane enol ether 34, and hydroxy ketone cyclization to the dioxepane system 40. The Z-diene system was established using a selenyl-Wittig reaction followed by syn elimination of the selenoxide to the diene. The α-vinyl functionality was installed using the Eschenmoser's salt methodology. The synthesis of hemibrevetoxin B(1) was achieved through a linear approach involving sequential formation of the oxepane rings (65 → 67 → 73) using the method of thionolactone formation followed by nucleophilic addition and regio/stereoselective hydroboration (67 → 68, 75 → 76). Elaboration of the side chains was carried out in a similar fashion as described for the epimer. The stereochemistry of the ring junctures in 1 and 2 and intermediates leading to them was established by X-ray crystallographic analysis carried out on compounds 45 and 54. Biological studies with (7aα)-epi-hemibrevetoxin B (2) revealed no binding for this molecule to the brevetoxin receptors.